Spyre Therapeutics
SYRE
14,29 €
Share price
1.27%
Change (1 day)
-55.27%
Change (1 year)
Categories
Spyre Therapeutics (SYRE) - Cash on Hand
Cash on Hand as of December 2024 : €0.55 Billion
According to Spyre Therapeutics's latest financial reports the company has €0.55 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Spyre Therapeutics - Cash on Hand chart (from 2014 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | €0.57 B | 88.83% |
| 2023-12-31 | €0.30 B | 490.93% |
| 2022-12-31 | €51.93 M | -36.84% |
| 2021-12-31 | €82.23 M | -30.85% |
| 2020-12-31 | €0.11 B | 85.16% |
| 2019-12-31 | €64.22 M | -1.39% |
| 2018-12-31 | €65.13 M | 55.37% |
| 2017-12-31 | €41.92 M | -30.56% |
| 2016-12-31 | €60.37 M | 99.66% |
| 2015-12-31 | €30.23 M | 1305.79% |
| 2014-12-31 | €2.15 M | -35.38% |
| 2013-12-31 | €3.32 M |